Nonfebrile seizures after febrile convulsions: possible role of chronic cytomegalovirus infection.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 6283054)

Published in J Pediatr on July 01, 1982

Authors

P Iannetti, M Fiorilli, M C Sirianni, A Paná, F Aiuti

Articles by these authors

Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med (1990) 2.69

Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am J Med Genet (1994) 2.68

Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. Clin Infect Dis (1999) 2.17

Biology of Kaposi's sarcoma. Eur J Cancer (2001) 2.07

Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01

Impaired production of interleukins in patients with cell-mediated immunodeficiencies. Clin Exp Immunol (1983) 1.55

Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol (1985) 1.52

Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes. Clin Exp Immunol (1973) 1.46

Plasma viraemia in seronegative HIV-1-infected individuals. AIDS (1991) 1.43

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis (1998) 1.29

Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24

gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood (1998) 1.22

Surface markers on lymphocytes of patients with infectious diseases. Infect Immun (1973) 1.21

Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia. J Clin Immunol (1992) 1.18

CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med (1995) 1.16

Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS). Clin Exp Immunol (1987) 1.15

Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin Exp Immunol (1991) 1.10

Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS (1999) 1.08

gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood (1998) 1.08

Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. Am J Med Genet (1988) 1.06

C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol (1997) 1.05

Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies. Clin Exp Immunol (1973) 1.05

Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today (1990) 1.04

Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol (1997) 1.04

Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol (1988) 1.04

Gastric pathology in patients with common variable immunodeficiency. Gut (1999) 1.04

TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood (1995) 1.03

Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood (1994) 1.03

Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol (2002) 1.03

Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.02

A patient with nucleoside phosphorylase deficiency, selective t-cell deficiency, and autoimmune hemolytic anemia. J Pediatr (1978) 1.02

Hepatitis C virus antibodies in gammaglobulin. Lancet (1990) 1.01

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Clin Exp Immunol (1999) 1.00

Patterns of covariation of DSM-IV personality disorders in a mixed psychiatric sample. Compr Psychiatry (2000) 0.99

Function and distribution pattern of human T lymphocytes. II. Presence of T lymphocytes in normal humans and in humans with various immunodeficiency disorders. Clin Exp Immunol (1973) 0.98

Complement activation is associated with the presence of specific human immunodeficiency virus (HIV)-anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome. Scand J Immunol (1989) 0.98

Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol (2001) 0.98

Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III. J Interferon Res (1986) 0.97

Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood (1997) 0.97

Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics (2005) 0.97

IgG subclasses to group B streptococci in normals, colonized woman and IgG2 subclass-deficient patients. Monogr Allergy (1988) 0.96

Protein A-positive staphylococci serve as a selective B cell mitogen for lymphocytes from primary immunodeficiency patients. Clin Exp Immunol (1979) 0.96

Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J Acquir Immune Defic Syndr (1992) 0.95

Delayed appearance of HIV infection in children. Lancet (1987) 0.95

Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod (1996) 0.95

Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology (1986) 0.95

T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol (2000) 0.94

Interferon production in primary immunodeficiencies. J Clin Immunol (1984) 0.94

Familial lymphopenia with T lymphocyte defect. J Pediatr (1974) 0.94

Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART. Clin Immunol (2000) 0.94

Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J Clin Immunol (1983) 0.93

Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet (1997) 0.93

Early-onset hereditary neuropathy with liability to pressure palsy. Neuropediatrics (2007) 0.93

Variant of ataxia-telangiectasia with low-level radiosensitivity. Hum Genet (1985) 0.93

Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat (2003) 0.93

Mixed cryoglobulinemia secondary to visceral Leishmaniasis. Arthritis Rheum (1999) 0.93

Phenotypically immature IgG-bearing B cells in patients with hypogammaglobulinemia. J Clin Immunol (1986) 0.92

Brief communication: criterion validity of the Personality Diagnostic Questionnaire-4+ (PDQ-4+) in a mixed psychiatric sample. J Pers Disord (1998) 0.92

Membrane-bound immunoglobulin (Ig) and in vitro production of Ig by lymphoid cells from patients with primary immunodeficiencies. Scand J Immunol (1973) 0.92

Heterogeneity of immunological abnormalities in ataxia-telangiectasia. J Clin Immunol (1983) 0.92

Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study. J Psychosom Res (1993) 0.92

CNS findings in three cases of septo-optic dysplasia, including one with semilobar holoprosencephaly. Am J Med Genet A (2005) 0.92

IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J (Clin Res Ed) (1985) 0.92

Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan. Infection (1985) 0.91

Delayed and defective anti-HIV IgM response in infants. Lancet (1987) 0.91

A case of Behćet's disease complicated by visceral Leishmaniasis and myelodysplasia: clinical considerations. Haematologica (2001) 0.91

Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. J Clin Immunol (1990) 0.91

Multiple sclerosis in children under 10 years of age. Neurol Sci (2004) 0.91

Detection and partial characterization of circulating immune complexes in hydatid disease. J Clin Microbiol (1983) 0.91

HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. Clin Exp Immunol (1995) 0.91

Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS. J Clin Microbiol (1993) 0.90

Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2000) 0.90

Circulating immune complexes detected by C1q solid phase assay in leprosy. Int J Lepr Other Mycobact Dis (1981) 0.90

Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol (1991) 0.90

In vitro lymphocyte proliferative response to HIV-1 p24 is associated with a lack of CD4+ cell decline. AIDS Res Hum Retroviruses (1994) 0.89

HCV infection in patients with primary defects of immunoglobulin production. Clin Exp Immunol (1995) 0.89

Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons. J Immunol (1999) 0.89

Serum and salivary IgA levels in normal subjects: comparison between tonsillectomized and non-tonsillectomized subjects. Int Arch Allergy Appl Immunol (1982) 0.89

Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinaemia. Clin Exp Immunol (1983) 0.89

Specific cellular unreactivity during cytomegalovirus infection in man. Boll Ist Sieroter Milan (1978) 0.88

Usefulness of monoclonal antibodies in the diagnosis and monitoring of patients with primary immunodeficiencies: combined experience in three clinical immunology centers. Diagn Immunol (1983) 0.88

Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes. Clin Exp Immunol (1988) 0.88